CID 135431100

Lodenafil carbonate

Structural Information

Molecular Formula
C47H62N12O11S2
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCOC(=O)OCCN5CCN(CC5)S(=O)(=O)C6=CC(=C(C=C6)OCC)C7=NC8=C(C(=O)N7)N(N=C8CCC)C)OCC)C
InChI
InChI=1S/C47H62N12O11S2/c1-7-11-35-39-41(54(5)52-35)45(60)50-43(48-39)33-29-31(13-15-37(33)67-9-3)71(63,64)58-21-17-56(18-22-58)25-27-69-47(62)70-28-26-57-19-23-59(24-20-57)72(65,66)32-14-16-38(68-10-4)34(30-32)44-49-40-36(12-8-2)53-55(6)42(40)46(61)51-44/h13-16,29-30H,7-12,17-28H2,1-6H3,(H,48,50,60)(H,49,51,61)
InChIKey
MVYUCRDXZXLFSB-UHFFFAOYSA-N
Compound name
bis[2-[4-[4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]sulfonylpiperazin-1-yl]ethyl] carbonate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

14
References

1433
Patents

1034.4103 Da
Monoisotopic Mass

3.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 1035.4176 258.3
[M+Na]+ 1057.3995 269.9
[M-H]- 1033.4030 247.1
[M+NH4]+ 1052.4441 258.8
[M+K]+ 1073.3735 247.3
[M+H-H2O]+ 1017.4076 240.4
[M+HCOO]- 1079.4085 259.9
[M+CH3COO]- 1093.4242 262.8
[M+Na-2H]- 1055.3850 246.2
[M]+ 1034.4098 281.1
[M]- 1034.4108 281.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe